Soluble HLA: Patterns of expression in normal subjects, autoimmune diseases, and transplant recipients

Rheumatology International

Volumn 25, Issue 7, 2005, Pages 491-500

  Adamashvili, Irena ^a   Kelley, Roger E ^a   Pressly, Thomas ^a   McDonald, John C ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Autoimmune disease; Major histocompatibility complex; Soluble HLA; Transplantation

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BLOOD CLOTTING FACTOR 8; HUMAN IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN; POLYPEPTIDE;

ALLOGRAFT; ALLOTYPE; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD LEVEL; BODY FLUID; BONE MARROW TRANSPLANTATION; CELL DESTRUCTION; CELL MEMBRANE; CELL SURFACE; CEREBROSPINAL FLUID LEVEL; CHEMICAL STRUCTURE; CHROMOSOME 6; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LACRIMAL FLUID; LIVER TRANSPLANTATION; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; REVIEW; RHEUMATOID ARTHRITIS; SALIVA; SERUM; SWEAT; SYNOVIAL FLUID LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MALE; ORGAN TRANSPLANTATION; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SWINE; TRANSPLANTATION IMMUNOLOGY;

EID: 25144462512     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0585-y     Document Type: Review

References (92)

1. Gussow D, Ploegh H (1987) Soluble class I antigens: a conundrum with no solution? Immunol Today 8:220
2. Calne RY, White HJ, Yoffa DE, Binns RM, Maginn RR, Herbertson RM, Millard PR, Molina VP, Davis DR (1967) Prolonged survival of liver transplants in the pig. Br Med J 2(550):487
3. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM, Binns RM, Davies DA (1969) Induction of immunological tolerance by porcine liver allografts. Nature 223(205):472
4. Van Rood JJ, van Leeuwen A, van Santen MCT (1970) Anti HL-A2 inhibitor in normal human serum. Nature 226:366
5. Charlton RK, Zmijewski CM (1970) Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science 170(958):636
6. Schultz JS, Shreffler DC (1975) Studies on the serum fraction containing soluble inhibitors of anti-HL-A sera. Transplantation 16(3):205
7. Aster RH, Miskovich BH, Rodey GE (1973) Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction. Transplantation 16(3):205
8. Jankowska-Gan E, Rhein T, Haynes LD, Geissler F, Mulder A, Kalayoglu M, Sollinger H, Burlingham WJ (1992) Human liver allograft acceptance and "tolerance assay". II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH. Hum Immunol 63(10):862
9. den Dulk M, Bishop GA (2003) Immune mechanisms contributing to spontaneous acceptance of liver transplants in rodents and their potential for clinical transplantation. Arch Immunol Ther Exp (Warsz) 51(1):29
10. Jendro M, Goronzy JJ, Weyand CM (1991) Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 8(4):289-296
11. Aultman D, Adamashvili I, Yaturu K, Langford M, Gelder F, Gautreaux M, Ghali GE, McDonald J (1999) Soluble HLA in human body fluids. Hum Immunol 60(3):239-244
12. Dobbe LM, Starn NJ, Neefjes JJ, Giphart MJ (1988) Biochemical complexity of serum HLA class I molecules. Immunogenetics 27(3):203
13. Krangel MS (1986) Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163(5):1173
14. Krangel MS (1987) Two forms of HLA class I molecules in human plasma. Hum Immunol 20(2):155
15. Haga JA, She JX, Kao KJ (1991) Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma. A secretable membrane protein derived from transmembrane domain deletion. J Biol Chem 266(6):3695
16. Hiraki DD, See-Tho K, Filvaroff E, Krishnaswamy S, de Bello W, Taidi-Laskowski B, Grumet FC (1994) Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dirnerization. Hum Immunol 40(3):235
17. Lucas ZJ (1970) An assay for antibodies to histocompatibility antigens based on inhibition of radioiodine-labeled antibody binding. Transplantation 10(6):512
18. Foschi GV, Manson LA (1970) Radioimmune assay for histocompatibility antigens. Nature 225(235):853
19. Miyakawa Y, Tanigaki N, Kreiter VP, Moore GE, Pressman D (1973) Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation 15(3):312
20. Tanigaki N, Miyakawa Y, Yagi Y (1973) Radioiodinated soluble HLA antigens: HLA alloantigenic characterization and use in radioimmunoassay. J Immunol Methods 3(2):109
21. Giphart MJ, Doyer E, Bruning JW, Rood JJ (1975) The application of radiolabelled HLA antibodies in the detection of (soluble) transplantation antigens: an alternative for the microcytotoxicity test. J Immunol Methods 9(2):105
22. Ferreira A, Revilla Y, Bootello A, Gonzalez-Porque P (1983) Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods 65(3):373
23. Russo C, Pellegrino MA, Ferrone S (1983) A double-determinant immunoassay with monoclonal antibodies to the HLA-A, B, C complex. Transplant Proc 15:66
24. Sakaguchi K, Ono R, Tsujisaki M, Richiardi P, Carbonara A, Park MS, Tonai R, Terasaki PI, Ferrone S (1988) Anti-HLA-B7, B27, Bw42, Bw54, Bw55, Bw56, Bw67, Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay. Hum Immunol 21(3):193
25. Comuzio S, Puppo P, Ruzzenenti R, Orlandini A, Grillo F, Brenci S, Lanza L, Scudeletti M, Indiveri F (1991) Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. J Clin Lab Anal 5(4):278
26. Doxiadis I, Westhoff U, Grosse-Wilde H (1989) Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59(5):449
27. Gelder FB, McDonald JC, Landreneau MD, McMillan RM, Aultman DF (1991) Identification, characterization, and quantitation of soluble HLA antigens in the circulation and peritoneal dialysate of renal patients. Ann Surg 213(6):591
28. McDonald JC, Gelder FB, Aultman DF, Landreneau MD, McMillan RW, Singh I, Sorrells D, Liou WH (1992) HLA in human serum: quantitation of class I by enzyme immunoassay. Transplantation 53(2):445
29. Indiveri F, Wilson BS, Natali PG, Pellegrino MA, Ferrone S (1980) Immunogenicity of DR antigens isolated from body fluids. Transplant Proc 12(1):121
30. Wu T, Lan J, Zhang H, Wang CR, Mao GC (2002) Detection of soluble HLA class I antigens by ELISA and determination of its reference value in population of Guangdong province. Di Yi Jun Yi Da Xue Xue Bao Yi K 22(10):931
31. Pellegrino MA, Russo C, Allison JP (1984) HLA antigens in serum. Methods Enzymol 108:614
32. Westhoff U, Thinnes FP, Gotz H, Grosse-Wilde H (1991) Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 61(2):106
33. Reisfeld RA, Allison JP, Ferrone S, Pellegrino MA, Poulik MD (1976) HL-A antigens in serum and urine: isolation, characterization, and immunogenic properties. Transplant Proc 8(2):173
34. Pellegrino MA, Ferrone S, Pellegrino AG, Oh SK, Reisfeld RA (1974) Evaluation of two sources of soluble HL-A antigens: platelets and serum. Eur J Immunol 4(4):250
35. Adamashvilli IM, Fraser PM, McDonald JC (1996) Association of serum concentrations of soluble class I HLA with HLA allotypes. Transplantation 61(6):984
36. Adamashvilli I, Wolf R, Aultman D, Milford EL, Jaffe S, Hall V, Pressly T, Minagar A, Kelley R (2003) Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus. Rheumatol Int 23(6):294
37. Zavazava N, Wobst B, Ferstl R, Muller-Ruchholtz W (1994) Soluble MHC class I molecules in human body fluids. J Clin Lab Anal 8(6):432
38. Nakanashi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K, Kosaka K (1993) Association of HLA-A24 with complete B-cell destruction in insulin-dependent diabetes mellitus. Diabetes 42:1086
39. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K (1993) Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780
40. Nakanishi K, Kobayashi T, Komatsu Y, Kogawa N, Hagihara M, Tsuji K (1993) Synchronous decline of serum-soluble HLA class I antigens and beta-cell function in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 85:246
41. Adamashvili I, McVie R, Gelder F, Gautreaux M, Jaramillo J, Roggero T, McDonald J (1997) Soluble HLA class I antigens in patients with type I diabetes and their family members. Hum Immunol 55(2):176-183
42. McDonald J, Adamashvili I, Hayes J, Aultman DF, Rhynes VK, Gelder FB (1994) Soluble HLA class II concentrations in normal individuals and transplant recipients: comparison with soluble class I concentrations. Transplantation 28:1268
43. Hagihara M, Shimura T, Yamamoto K, Takebe K, Munkhbat B, Tsuji K (1994) Soluble HLA class I and class II in Japanese. Hum Immunol 40(3):171
44. Weyand CM, Jendro M, Goronzy JJ (1991) Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 8(4):281
45. Adamashvili I, Fraser PA, Milford EL, Sittig K, Gebel H, Zibari G, Pressly T, McDonald JC (2002) Soluble HLA-II expression in African-Americans. Inflamm Res 51(6):290
46. Adamashvili IM, McDonald JC, Fraser PA, Milford EL, Pressly TA, Gelder FB (1995) Soluble class I HLA antigens in patients with rheumatoid arthritis and their families. J Rheumatol 22:1025
47. Tsuchiya N, Shiota M, Yamaguchi A, Ito K (1996) Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus. Arthritis Rheum 39(5):792
48. Sakaguchi K, Koide N, Takenami T, Matsushima H, Takabatake H, Ferrone S, Tsuji T (1992) Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn 27(2):206
49. Inostroza J, Munoz P, Espinoza R, Millaqueo L, Diaz P, Leiva L, Sorensen R (1997) Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis. Hum Immunol 40(3):179
50. Inostroza J, Fertada J, Navarrete C, Sorensen RU (1997) Soluble histocompatibility class I antigens and beta 2-microglobulin in pregnant females and cord blood samples. Hum Immunol 54(1):63
51. Sandrin MS, Henning MM, Vaughan HA, McKenzie IF, Parish CR (1981) Serum Ia levels during tumor growth in mice and humans. J Natl Cancer Inst 66(2):279
52. Shimura T, Hagihara M, Yamamoto K, Takebe K, Munkhbat B, Ogoshi K, Mitomi T, Nagamachi Y, Tsuji K (1994) Quantification of serum-soluble HLA class I antigens in patients with gastric cancer. Hum Immunol 40(3):183
53. Hagihara M, Shimura T, Takebe K, Munkhbat B, Hosoi K, Kagawa T, Watanabe N, Matsuzaki S, Yamamoto K, Sato K, Tsuji K (1997) Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 32:338-43
54. Filaci G, Contini P, Brenci S, Lanza L, Scudeletti M, Indiveri F, Puppo F (1995) Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 46(2):117
55. Herlyn M, Lange B, Bennicelli J, Blaszczyk M, Guerry D 4th, Koprowski H (1984) Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk Res 8(3):323
56. Stevenson FK, George AJ, Walters MT, Hamblin TJ (1986) Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods 86:187
57. Finardi E, Granier E, Tola MR, Melchiorri L, Vaghi L, Rizzo R, Castellazzi M, Ceruti S, Paolino E, Baricordi OR (2002) Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules. J Neuroimmunol 133:151
58. Filaci G, Contini P, Brenci S, Gazzola P, Lanza L, Scudeletti M, Indiveri F, Mancardi GL, Puppo F (1997) HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum Immunol 54(1):54
59. Stevenson FK, Douglas WA, Spellerberg MB, Walters MT, Cawley MI (1990) Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol 80:32
60. Adamashvili I, Pressly T, Gebel H, Milford E, Wolf R, Mancini M, Sittg K, Ghali GE, Hall V, McDonald JC (2002) Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Rheumatol Int 22:71-76
61. Kamada N (1985) The immunology of experimental liver transplantation in the rat. Immunology 55(3):369
62. Davies HS, Pollard SG, Calne RY (1989) Soluble HLA antigens in the circulation of liver graft patients. Transplantation 47(3):524
63. Tsuji K, Kusama M, Nakatsuji T et al (1985) Biological significance of Ss (serum soluble) HLA-class I antigens in bone marrow transplantation. Tokai J Exp Clin Med 10(2-3):169
64. Liem LM, Koelman CA, Doxiadis II, van Houwelingen JC, Goulmy E, Claas FH (1997) Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transplant 20(3):227
65. Rhynes VK, McDonald JC, Gelder FB, Aultman DF, Hayes JM, McMillan RW, Mancini MC (1993) Soluble HLA class I in the serum of transplant recipients. Ann Surg 217(5):485
66. Zavazava N, Bottcher H, Ruchholtz WM (1993) Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 42(1):20
67. Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ghio M, Scudeletti M, Barocci S, Valente U, Indiveri F (1995) HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 40(3):166
68. Molajoni ER, Puppo F, Brenci S, Scudeletti M, Cinti P, Alfani D, Indiveri F, Cortesini R (1995) Serum HLA class I soluble antigens: a marker of acute rejection following liver transplantation. Transplant Proc 27(1):1155
69. McMillan RM, Gelder FB, Zibari GB, Aultman DF, Adamashvili I, MacDonald JC (1998) Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients. Clin Transplant 11:98
70. Pollard SG, Davies HS, Calne RY (1989) Soluble HLA antigens in human bile. Transplantation 48(4):712
71. Pollard SG, Davies HF, Calne RY (1990) Preoperative appearance of serum class I antigen during liver transplantation. Transplantation 49(3):659
72. McDonald JC, Adamashvili I, Zibari GB, Aultman DF, Mancini MC, McMillan RW, Gelder FB (1997) Serologic allogeneic chimerism. Transplantation 64(6):865
73. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ (1994) Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40(3):191
74. Smith MA, Naziruddin B, Poindexter NJ, Haynes AE, Howard T, Mohanakumar T (2000) Liver transplant recipient sera derived soluble HLA mediates allele specific CTL apoptosis. Transplantation 15; 69(1):157
75. Haga JA, Riley WJ, Kao KJ (1991) Effect of HLA phenotype and gender on expression of various forms of class I HLA in plasma. Hum Immunol 32(2):79
76. Rebmann V, Passler M, Erhard J, Lange R, Eigler FW, Grosse-Wilde H (1999) Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol 60(5):424
77. Adamashvili I, Kelley R, Zibari G, Aultman D, Sittig K, Mancini M, Smith L, Minagar A, Takemoto S (2004) Variable forms of HLA class I molecules in serum of liver transplant recipients. Tex Med 16:44
78. Reed E, Beer AE, Hutcherson H, King DW, Suciu-Foca N (1991) The alloantibody response of pregnant women and its suppression by soluble HLA antigens and anti-idiotypic antibodies. J Reprod Immunol 20(2):115
79. King DW, Reed E, Suciu-Foca N (1989) Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol Res 8(4):249
80. Kamada N, Shinomiya T (1985) Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 55(1):85
81. Guencheva G, Scholz S, Schiessl B, Albert ED (1982) Soluble HLA antigens in normal human immunoglobulin preparations. Tissue Antigens 19(3):198
82. Gross-Wilde H, Blasczyk R, Westhoff U (1992) Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations. Tissue Antigens 39(2):74
83. Santoso S, Kiefel V, Volz H, Mueller-Eckhardt C (1992) Quantitation of soluble HLA class I antigen in human albumin and immunoglobulin preparations for intravenous use by solid-phase immunoassay. Vox Sang 62(1):29
84. Westhoff U, Grosse-Wilde H (1995) Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Vox Sang 68(2):73
85. Sumimoto R, Kamada N (1990) Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50(4):678
86. Krensky AM (1994) T cells in autoimmune and allograft rejection. Kidney Int Suppl 44:S50
87. Krensky AM, Clayberger C (1995) HLA-derived peptides as novel immunotherapeutics. Clin Immunol Pathol 75(2):112
88. Krensky AM, Clayberger C (1995) Human leukocyte antigen-derived peptides as novel immunosuppressives. Proc Assoc Am Physicians 107(1):81
89. Claus R, Hausmann S, Zavazava N, Walzel H, Schulze HA, Kohler H, Friemel H, Muller-Ruchholtz W (1994) In vitro effects of solubilized HLA-DR - role in immunoregulation? Cell Immunol 155(2):476
90. Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, Newsom-Davis J (1994) Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 93(4):1361
91. Pri R, Lee J, Shih N, Chen M, Terasaki PI (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 15 (1):43
92. Zavazava N, Kronke M (1996) Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 2(9):1005